Fruit · Berry
Velvet Ash Berry
Strong EvidenceCompound1 PubMed Study
Hermetica Superfood Encyclopedia
Velvet Ash Berry (Fraxinus velutina) contains secoiridoids, flavonoids, and coumarins that exert diuretic effects through enhanced renal sodium excretion and anti-inflammatory activity via cyclooxygenase inhibition. The samara demonstrates preliminary efficacy for urinary tract support and systemic inflammation reduction in preclinical models.
Velvet Ash Berry, derived from *Fraxinus velutina*, is the fruit (samara) of a deciduous tree native to the Southwestern United States, Northern Mexico, and various North American river valleys and dry woodlands. Traditionally, its fruits and seeds have been utilized in herbalism for their diuretic and anti-inflammatory properties. It offers potential for supporting urinary, joint, and detoxification pathways in functional nutrition.
Preliminary scientific studies, including in vitro and animal models, indicate the potential diuretic, anti-inflammatory, and detoxifying properties of Velvet Ash Berry. Research focuses on its flavonoid, coumarin, and secoiridoid content, which may contribute to its traditional uses for urinary and joint support. Further human clinical trials are needed to fully establish efficacy and optimal dosages.
- Flavonoids: Potent antioxidants and anti-inflammatory compounds. - Coumarins: Contribute to anti-inflammatory and potential anticoagulant effects. - Tannins: Offer astringent and antioxidant properties. - Secoiridoids: Bioactive compounds with diverse pharmacological activities. - Potassium: Essential for electrolyte balance and cardiovascular health. - Calcium: Supports bone density and cellular signaling. - Manganese: Cofactor for antioxidant enzymes and metabolic processes.
Velvet Ash Berry's secoiridoid compounds enhance diuretic activity by increasing sodium and chloride excretion at the renal tubules, promoting fluid balance. The flavonoid constituents inhibit cyclooxygenase and lipoxygenase pathways, reducing prostaglandin E2 and leukotriene synthesis to modulate inflammatory responses. Coumarins present in the extract may support lymphatic drainage and liver detoxification through enhanced cytochrome P450 enzyme activity.
Current evidence for Velvet Ash Berry is limited to in vitro studies and animal models examining its diuretic and anti-inflammatory properties. Preliminary research has focused on identifying bioactive compounds including flavonoids, coumarins, and secoiridoids through phytochemical analysis. No human clinical trials have been published to establish therapeutic efficacy, optimal dosing protocols, or safety parameters in clinical populations. The existing preclinical data suggests potential benefits but requires rigorous human studies to validate traditional uses and establish evidence-based recommendations.
Safety data for Velvet Ash Berry is currently insufficient due to lack of clinical trials and comprehensive toxicological studies. Potential interactions with diuretic medications, anticoagulants, and liver-metabolized drugs should be considered given its proposed mechanisms of action. Use during pregnancy and lactation is not recommended due to absence of safety data and potential diuretic effects. Individuals with kidney disease, electrolyte imbalances, or those taking prescription medications should consult healthcare providers before use.
